Logo image of AVAH

AVEANNA HEALTHCARE HOLDINGS (AVAH) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:AVAH - US05356F1057 - Common Stock

9.34 USD
+0.07 (+0.76%)
Last: 11/28/2025, 8:13:32 PM
9.34 USD
0 (0%)
After Hours: 11/28/2025, 8:13:32 PM
Fundamental Rating

4

AVAH gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. While AVAH is still in line with the averages on profitability rating, there are concerns on its financial health. AVAH has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

AVAH had positive earnings in the past year.
In the past year AVAH had a positive cash flow from operations.
AVAH had negative earnings in each of the past 5 years.
In multiple years AVAH reported negative operating cash flow during the last 5 years.
AVAH Yearly Net Income VS EBIT VS OCF VS FCFAVAH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

AVAH has a Return On Assets of 1.05%. This is comparable to the rest of the industry: AVAH outperforms 52.48% of its industry peers.
AVAH has a Return On Invested Capital of 12.61%. This is amongst the best in the industry. AVAH outperforms 89.11% of its industry peers.
The Average Return On Invested Capital over the past 3 years for AVAH is below the industry average of 9.26%.
The 3 year average ROIC (5.94%) for AVAH is below the current ROIC(12.61%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.05%
ROE N/A
ROIC 12.61%
ROA(3y)-15.89%
ROA(5y)-11.16%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.94%
ROIC(5y)5.12%
AVAH Yearly ROA, ROE, ROICAVAH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5K 10K 15K

1.3 Margins

With a Profit Margin value of 0.85%, AVAH perfoms like the industry average, outperforming 54.46% of the companies in the same industry.
The Operating Margin of AVAH (9.95%) is better than 78.22% of its industry peers.
In the last couple of years the Operating Margin of AVAH has grown nicely.
AVAH has a better Gross Margin (33.33%) than 62.38% of its industry peers.
In the last couple of years the Gross Margin of AVAH has remained more or less at the same level.
Industry RankSector Rank
OM 9.95%
PM (TTM) 0.85%
GM 33.33%
OM growth 3Y7.46%
OM growth 5Y9.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.96%
GM growth 5Y0.71%
AVAH Yearly Profit, Operating, Gross MarginsAVAH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AVAH is creating some value.
The number of shares outstanding for AVAH has been increased compared to 1 year ago.
Compared to 5 years ago, AVAH has more shares outstanding
The debt/assets ratio for AVAH has been reduced compared to a year ago.
AVAH Yearly Shares OutstandingAVAH Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
AVAH Yearly Total Debt VS Total AssetsAVAH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

Based on the Altman-Z score of 1.24, we must say that AVAH is in the distress zone and has some risk of bankruptcy.
AVAH's Altman-Z score of 1.24 is on the low side compared to the rest of the industry. AVAH is outperformed by 66.34% of its industry peers.
AVAH has a debt to FCF ratio of 18.43. This is a negative value and a sign of low solvency as AVAH would need 18.43 years to pay back of all of its debts.
The Debt to FCF ratio of AVAH (18.43) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 18.43
Altman-Z 1.24
ROIC/WACC1.24
WACC10.2%
AVAH Yearly LT Debt VS Equity VS FCFAVAH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

AVAH has a Current Ratio of 1.09. This is a normal value and indicates that AVAH is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.09, AVAH is doing worse than 63.37% of the companies in the same industry.
A Quick Ratio of 1.09 indicates that AVAH should not have too much problems paying its short term obligations.
AVAH has a Quick ratio of 1.09. This is comparable to the rest of the industry: AVAH outperforms 42.57% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09
AVAH Yearly Current Assets VS Current LiabilitesAVAH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 2500.00% over the past year.
The earnings per share for AVAH have been decreasing by -49.58% on average. This is quite bad
The Revenue has been growing slightly by 6.82% in the past year.
The Revenue has been growing slightly by 7.90% on average over the past years.
EPS 1Y (TTM)2500%
EPS 3Y-49.58%
EPS 5YN/A
EPS Q2Q%650%
Revenue 1Y (TTM)6.82%
Revenue growth 3Y6.44%
Revenue growth 5Y7.9%
Sales Q2Q%22.18%

3.2 Future

The Earnings Per Share is expected to grow by 131.73% on average over the next years. This is a very strong growth
AVAH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.97% yearly.
EPS Next Y849.27%
EPS Next 2Y229.81%
EPS Next 3Y131.73%
EPS Next 5YN/A
Revenue Next Year16.19%
Revenue Next 2Y11.39%
Revenue Next 3Y8.97%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
AVAH Yearly Revenue VS EstimatesAVAH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
AVAH Yearly EPS VS EstimatesAVAH Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 0.4 0.6

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 19.46, the valuation of AVAH can be described as rather expensive.
Based on the Price/Earnings ratio, AVAH is valued a bit cheaper than the industry average as 75.25% of the companies are valued more expensively.
AVAH is valuated rather cheaply when we compare the Price/Earnings ratio to 26.31, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 17.17, which indicates a rather expensive current valuation of AVAH.
AVAH's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AVAH is cheaper than 70.30% of the companies in the same industry.
AVAH's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.59.
Industry RankSector Rank
PE 19.46
Fwd PE 17.17
AVAH Price Earnings VS Forward Price EarningsAVAH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

AVAH's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AVAH is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 24.85
EV/EBITDA 15.2
AVAH Per share dataAVAH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AVAH's earnings are expected to grow with 131.73% in the coming years.
PEG (NY)0.02
PEG (5Y)N/A
EPS Next 2Y229.81%
EPS Next 3Y131.73%

0

5. Dividend

5.1 Amount

No dividends for AVAH!.
Industry RankSector Rank
Dividend Yield N/A

AVEANNA HEALTHCARE HOLDINGS

NASDAQ:AVAH (11/28/2025, 8:13:32 PM)

After market: 9.34 0 (0%)

9.34

+0.07 (+0.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)03-11 2026-03-11/amc
Inst Owners19.39%
Inst Owner Change3.6%
Ins Owners5.67%
Ins Owner Change4.53%
Market Cap1.95B
Revenue(TTM)2.02B
Net Income(TTM)18.55M
Analysts76
Price Target10.77 (15.31%)
Short Float %6.21%
Short Ratio2.85
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3684.14%
Min EPS beat(2)412.4%
Max EPS beat(2)6955.89%
EPS beat(4)4
Avg EPS beat(4)2421.48%
Min EPS beat(4)256.86%
Max EPS beat(4)6955.89%
EPS beat(8)7
Avg EPS beat(8)1235.02%
EPS beat(12)9
Avg EPS beat(12)807.07%
EPS beat(16)9
Avg EPS beat(16)598.72%
Revenue beat(2)2
Avg Revenue beat(2)7.41%
Min Revenue beat(2)6.85%
Max Revenue beat(2)7.96%
Revenue beat(4)4
Avg Revenue beat(4)4.36%
Min Revenue beat(4)0.61%
Max Revenue beat(4)7.96%
Revenue beat(8)7
Avg Revenue beat(8)2.61%
Revenue beat(12)9
Avg Revenue beat(12)1.59%
Revenue beat(16)10
Avg Revenue beat(16)0.12%
PT rev (1m)22.02%
PT rev (3m)36.29%
EPS NQ rev (1m)26.01%
EPS NQ rev (3m)47.45%
EPS NY rev (1m)6.35%
EPS NY rev (3m)10.85%
Revenue NQ rev (1m)2.36%
Revenue NQ rev (3m)2.73%
Revenue NY rev (1m)0.81%
Revenue NY rev (3m)0.81%
Valuation
Industry RankSector Rank
PE 19.46
Fwd PE 17.17
P/S 0.9
P/FCF 24.85
P/OCF 22.76
P/B N/A
P/tB N/A
EV/EBITDA 15.2
EPS(TTM)0.48
EY5.14%
EPS(NY)0.54
Fwd EY5.82%
FCF(TTM)0.38
FCFY4.02%
OCF(TTM)0.41
OCFY4.39%
SpS10.42
BVpS-0.05
TBVpS-5.86
PEG (NY)0.02
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.05%
ROE N/A
ROCE 15.97%
ROIC 12.61%
ROICexc 13.63%
ROICexgc 399.63%
OM 9.95%
PM (TTM) 0.85%
GM 33.33%
FCFM 3.61%
ROA(3y)-15.89%
ROA(5y)-11.16%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.94%
ROIC(5y)5.12%
ROICexc(3y)6.24%
ROICexc(5y)5.39%
ROICexgc(3y)148.4%
ROICexgc(5y)163.95%
ROCE(3y)7.54%
ROCE(5y)6.51%
ROICexgc growth 3Y3.46%
ROICexgc growth 5Y50.58%
ROICexc growth 3Y35.54%
ROICexc growth 5Y22.27%
OM growth 3Y7.46%
OM growth 5Y9.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.96%
GM growth 5Y0.71%
F-Score8
Asset Turnover1.23
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 18.43
Debt/EBITDA 5.88
Cap/Depr -1158.75%
Cap/Sales 0.33%
Interest Coverage 1.5
Cash Conversion 39.69%
Profit Quality 423.16%
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z 1.24
F-Score8
WACC10.2%
ROIC/WACC1.24
Cap/Depr(3y)53.12%
Cap/Depr(5y)65.29%
Cap/Sales(3y)0.44%
Cap/Sales(5y)0.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2500%
EPS 3Y-49.58%
EPS 5YN/A
EPS Q2Q%650%
EPS Next Y849.27%
EPS Next 2Y229.81%
EPS Next 3Y131.73%
EPS Next 5YN/A
Revenue 1Y (TTM)6.82%
Revenue growth 3Y6.44%
Revenue growth 5Y7.9%
Sales Q2Q%22.18%
Revenue Next Year16.19%
Revenue Next 2Y11.39%
Revenue Next 3Y8.97%
Revenue Next 5YN/A
EBIT growth 1Y82.83%
EBIT growth 3Y14.38%
EBIT growth 5Y18.06%
EBIT Next Year83.91%
EBIT Next 3Y27.57%
EBIT Next 5YN/A
FCF growth 1Y349.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y488.65%
OCF growth 3YN/A
OCF growth 5YN/A

AVEANNA HEALTHCARE HOLDINGS / AVAH FAQ

What is the ChartMill fundamental rating of AVEANNA HEALTHCARE HOLDINGS (AVAH) stock?

ChartMill assigns a fundamental rating of 4 / 10 to AVAH.


What is the valuation status of AVEANNA HEALTHCARE HOLDINGS (AVAH) stock?

ChartMill assigns a valuation rating of 5 / 10 to AVEANNA HEALTHCARE HOLDINGS (AVAH). This can be considered as Fairly Valued.


How profitable is AVEANNA HEALTHCARE HOLDINGS (AVAH) stock?

AVEANNA HEALTHCARE HOLDINGS (AVAH) has a profitability rating of 4 / 10.


Can you provide the financial health for AVAH stock?

The financial health rating of AVEANNA HEALTHCARE HOLDINGS (AVAH) is 2 / 10.